In vivo tracking of superparamagnetic iron oxide nanoparticle-labeled mesenchymal stem cell tropism to malignant gliomas using magnetic resonance imaging: Laboratory investigation

Journal of Neurosurgery

Volumn 108, Issue 2, 2008, Pages 320-329

  Wu, Xing ^a   Hu, Jin ^b   Zhou, Liangfu ^a   Mao, Ying ^a   Yang, Bojie ^a   Gao, Liang ^a   Xie, Rong ^a   Xu, Feng ^a   Zhang, Dong ^a   Liu, Jun ^a   Zhu, Jianhong ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Glioma; Magnetic resonance imaging; Mesenchymal stem cell; Migration; Rat; Superparamagnetic iron oxide nanoparticle

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FERRIC FERROCYANIDE; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FIBROBLAST; FISCHER 344 RAT; FLUORESCENCE; GLIOBLASTOMA; GLIOMA CELL; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; STEM CELL TRANSPLANTATION;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; COLORING AGENTS; CONTRAST MEDIA; FERROCYANIDES; FIBROBLASTS; FLUORESCENT DYES; GLIOMA; GREEN FLUORESCENT PROTEINS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NANOPARTICLES; NEOPLASM TRANSPLANTATION; OXIDES; RATS; RATS, INBRED F344; TROPISM;

EID: 38949113727     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/JNS/2008/108/2/0320     Document Type: Article

References (53)

1. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, et al: Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci U S A 97:12846-12851, 2000
2. Anderson SA, Glod J, Arbab AS, Noel M, Ashari P, Fine HA, et al: Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 105:420-425, 2005
3. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, et al: Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 229: 838-846, 2003
4. Arbab AS, Pandit SD, Anderson SA, Yocum GT, Bur M, Frenkel V, et al: Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells 24:671-678, 2006
5. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, et al: Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 104: 1217-1223, 2004
6. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, et al: Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed 18: 553-559, 2005
7. Arbab AS, Yocum GT, Wilson LB, Parwana A, Jordan EK, Kalish H, et al: Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 3:24-32, 2004
8. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kied-rowski M, et al: Effect of stromal-cell-derived factor 1 on stemcell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697-703, 2003
9. Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, et al: Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res 63:1969-1974, 2003
10. Benedetti S, Pirola B, Pollo B, Magrassi L, Bruzzone MG, Rigamonti D, et al: Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 6:447-450, 2000
11. Bos C, Delmas Y, Desmouliere A, Solanilla A, Hauger O, Grosset C, et al: In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 233:781-789, 2004
12. Brown AB, Yang W, Schmidt NO, Carroll R, Leishear KK, Rainov NG, et al: Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 14:1777-1785, 2003
13. Bulte JW, Kraitchman DL: Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499, 2004
14. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, et al: Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858-864, 2004
15. De Palma M, Venneri MA, Galli R, Sergi LS, Politi LS, Sampaolesi M, et al: Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211-226, 2005
16. Dunn IF, Black PM: The neurosurgeon as local oncologist: cellular and molecular neurosurgery in malignant glioma therapy. Neurosurgery 52:1411-1424, 2003
17. Dwenger A, Rosenthal F, Machein M, Waller C, Spyridonidis A: Transplanted bone marrow cells preferentially home to the vessels of in situ generated murine tumors rather than of normal organs. Stem Cells 22:86-92, 2004
18. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, et al: Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62:7170-7174, 2002
19. Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS: The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 62:5657-5663, 2002
20. Ehtesham M, Yuan X, Kabos P, Chung NH, Liu G, Akasaki Y, et al: Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 6:287-293, 2004
21. Ferrari N, Glod J, Lee J, Kobiler D, Fine HA: Bone marrow-derived, endothelial progenitor-like cells as angiogenesis-selective gene-targeting vectors. Gene Ther 10:647-656, 2003
22. Frank JA, Miller BR, Arbab AS, Zywicke HA, Jordan EK, Lewis BK, et al: Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 228:480-487, 2003
23. Grossman SA, Batara JF: Current management of glioblastoma multiforme. Semin Oncol 31:635-644, 2004
24. Hamada H, Kobune M, Nakamura K, Kawano Y, Kato K, Honmou O, et al: Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96:149-156, 2005
25. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al: Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-1622, 2004
26. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G, et al: CD133 positive endothelial progenitor cells contribute to the tumour vasculature in non-small cell lung cancer. J Clin Pathol 57:965-969, 2004
27. Imitola J, Raddassi K, Park KI, Mueller FJ, Nieto M, Teng YD, et al: Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101:18117-18122, 2004
28. Keles GE, Berger MS: Advances in neurosurgical technique in the current management of brain tumors. Semin Oncol 31:659-665, 2004
29. Kim SK, Cargioli TG, Machluf M, Yang W, Sun Y, Al-Hashem R, et al: PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin Cancer Res 11:5965-5970, 2005
30. Lee J, Elkahloun AG, Messina SA, Ferrari N, Xi D, Smith CL, et al: Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: a potential antiglioma cellular vector. Cancer Res 63:8877-8889, 2003
31. Lefranc F, Brotchi J, Kiss R: Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23:2411-2422, 2005
32. Machein MR, Renninger S, de Lima-Hahn E, Plate KH: Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas. Brain Pathol 13:582-597, 2003
33. Magnitsky S, Watson DJ, Walton RM, Pickup S, Bulte JW, Wolfe JH, et al: In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage 26:744-754, 2005
34. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, et al: Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Radiology 235:155-161, 2005
35. Moore XL, Lu J, Sun L, Zhu CJ, Tan P, Wong MC: Endothelial progenitor cells' "homing" specificity to brain tumors. Gene Ther 11:811-818, 2004
36. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, et al: Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 65:3307-3318, 2005
37. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, et al: Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155-1164, 2004
38. Peters BA, Diaz LA, Polyak K, Meszler L, Romans K, Guinan EC, et al: Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11:261-262, 2005
39. Phinney DG, Isakova I: Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr Pharm Des 11: 1255-1265, 2005
40. Rempel SA, Dudas S, Ge S, Gutierrez JA: Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6:102-111, 2000
41. Rich JN, Bigner DD: Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3:430-446, 2004
42. Rosu-Myles M, Stewart E, Trowbridge J, Ito CY, Zandstra P, Bhatia M: A unique population of bone marrow cells migrates to skeletal muscle via hepatocyte growth factor/c-met axis. J Cell Sci 118:4343-4352, 2005
43. Ruzinova MB, Schoer RA, Gerald W, Egan JE, Pandolfi PP, Rafii S, et al: Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277-289, 2003
44. Salmaggi A, Gelati M, Pollo B, Frigerio S, Eoli M, Silvani A, et al: CXCL12 in malignant glial tumors: a possible role in angiogenesis and cross-talk between endothelial and tumoral cells. J Neurooncol 67:305-317, 2004
45. Salmaggi A, Gelati M, Pollo B, Marras C, Silvani A, Balestrini MR, et al: CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients. J Neurooncol 74:287-293, 2005
46. Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T, et al: Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 106:419-427, 2005
47. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 62: 3603-3608, 2002
48. Tille JC, Pepper MS: Mesenchymal cells potentiate vascular endothelial growth factor-induced angiogenesis in vitro. Exp Cell Res 280:179-191, 2002
49. Uhl M, Weiler M, Wick W, Jacobs AH, Weller M, Herrlinger U: Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas. Biochem Biophys Res Commun 328:125-129, 2005
50. Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, et al: MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 7:113-117, 2002
51. Wynn RF, Hart CA, Corradi-Perini C, O'Neill L, Evans CA, Wraith JE, et al: A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104:2643-2645, 2004
52. Yaşargil MG, Kadri PA, Yaşargil DC: Microsurgery for malignant gliomas. J Neurooncol 69:67-81, 2004
53. Zhang Z, Jiang Q, Jiang F, Ding G, Zhang R, Wang L, et al: In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage 23:281-287, 2004